{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:44:49Z","timestamp":1793450689398,"version":"4.5.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,7,11]]},"abstract":"<jats:sec id=\"ab-joi230065-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Genomic testing in infancy guides medical decisions and can improve health outcomes. However, it is unclear whether genomic sequencing or a targeted neonatal gene-sequencing test provides comparable molecular diagnostic yields and times to return of results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230065-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare outcomes of genomic sequencing with those of a targeted neonatal gene-sequencing test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230065-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>The Genomic Medicine for Ill Neonates and Infants (GEMINI) study was a prospective, comparative, multicenter study of 400 hospitalized infants younger than 1 year of age (proband) and their parents, when available, suspected of having a genetic disorder. The study was conducted at 6 US hospitals from June 2019 to November 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230065-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Enrolled participants underwent simultaneous testing with genomic sequencing and a targeted neonatal gene-sequencing test. Each laboratory performed an independent interpretation of variants guided by knowledge of the patient\u2019s phenotype and returned results to the clinical care team. Change in clinical management, therapies offered, and redirection of care was provided to families based on genetic findings from either platform.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230065-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Primary end points were molecular diagnostic yield (participants with \u22651 pathogenic variant or variant of unknown significance), time to return of results, and clinical utility (changes in patient care).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230065-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A molecular diagnostic variant was identified in 51% of participants (n\u2009=\u2009204; 297 variants identified with 134 being novel). Molecular diagnostic yield of genomic sequencing was 49% (95% CI, 44%-54%) vs 27% (95% CI, 23%-32%) with the targeted gene-sequencing test. Genomic sequencing did not report 19 variants found by the targeted neonatal gene-sequencing test; the targeted gene-sequencing test did not report 164 variants identified by genomic sequencing as diagnostic. Variants unidentified by the targeted genomic-sequencing test included structural variants longer than 1 kilobase (25.1%) and genes excluded from the test (24.6%) (McNemar odds ratio, 8.6 [95% CI, 5.4-14.7]). Variant interpretation by laboratories differed by 43%. Median time to return of results was 6.1 days for genomic sequencing and 4.2 days for the targeted genomic-sequencing test; for urgent cases (n\u2009=\u2009107) the time was 3.3 days for genomic sequencing and 4.0 days for the targeted gene-sequencing test. Changes in clinical care affected 19% of participants, and 76% of clinicians viewed genomic testing as useful or very useful in clinical decision-making, irrespective of a diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi230065-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The molecular diagnostic yield for genomic sequencing was higher than a targeted neonatal gene-sequencing test, but the time to return of routine results was slower. Interlaboratory variant interpretation contributes to differences in molecular diagnostic yield and may have important consequences for clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2023.9350","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T11:01:03Z","timestamp":1689073263000},"page":"161","source":"Crossref","is-referenced-by-count":85,"title":["Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder"],"prefix":"10.1001","volume":"330","author":[{"given":"Jill L.","family":"Maron","sequence":"first","affiliation":[{"name":"Women and Infants Hospital of Rhode Island, Providence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kingsmore","sequence":"additional","affiliation":[{"name":"Rady Children\u2019s Institute for Genomic Medicine, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Gelb","sequence":"additional","affiliation":[{"name":"Mindich Child Health and Development Institute and Departments of Pediatrics and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Vockley","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center Children\u2019s Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Wigby","sequence":"additional","affiliation":[{"name":"Rady Children\u2019s Institute for Genomic Medicine, San Diego, California"},{"name":"Department of Pediatrics, University of California San Diego, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bragg","sequence":"additional","affiliation":[{"name":"Mindich Child Health and Development Institute and Departments of Pediatrics and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Stroustrup","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Cohen Children\u2019s Medical Center at Northwell Health, New Hyde Park, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Poindexter","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Suhrie","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine, Department of Pediatrics and Medical and Molecular Genetics, Indianapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae H.","family":"Kim","sequence":"additional","affiliation":[{"name":"Perinatal Institute, Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Diacovo","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center Children\u2019s Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Powell","sequence":"additional","affiliation":[{"name":"University of North Carolina Children\u2019s Research Institute, University of North Carolina Children\u2019s Hospital, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Trembath","sequence":"additional","affiliation":[{"name":"University of North Carolina Children\u2019s Research Institute, University of North Carolina Children\u2019s Hospital, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Guidugli","sequence":"additional","affiliation":[{"name":"Rady Children\u2019s Institute for Genomic Medicine, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna A.","family":"Ellsworth","sequence":"additional","affiliation":[{"name":"Rady Children\u2019s Institute for Genomic Medicine, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallas","family":"Reed","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kurfiss","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis L.","family":"Breeze","sequence":"additional","affiliation":[{"name":"Tufts Clinical and Translational Science Institute, Tufts University, and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Trinquart","sequence":"additional","affiliation":[{"name":"Tufts Clinical and Translational Science Institute, Tufts University, and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tufts Medical Center, Boston, Massachusetts"},{"name":"Tufts Clinical and Translational Science Institute, Tufts University, and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"joi230065r1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ajhg.2019.08.009","article-title":"A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants.","volume":"105","author":"Kingsmore","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"5","key":"joi230065r2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ajhg.2020.10.003","article-title":"An RCT of rapid genomic sequencing among seriously ill infants results in high clinical utility, changes in management, and low perceived harm.","volume":"107","author":"Dimmock","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"12","key":"joi230065r3","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jamapediatrics.2021.3496","article-title":"Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease.","volume":"175","author":"Krantz","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"6","key":"joi230065r4","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.gim.2022.03.005","article-title":"Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions.","volume":"24","author":"Lavelle","year":"2022","journal-title":"Genet Med"},{"issue":"1","key":"joi230065r5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/cge.v101.1","article-title":"Use of medical exome sequencing for identification of underlying genetic defects in NICU.","volume":"101","author":"Yang","year":"2022","journal-title":"Clin Genet"},{"issue":"12","key":"joi230065r6","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1007\/s00431-021-04115-x","article-title":"Rapid exome sequencing: revolutionises the management of acutely unwell neonates.","volume":"180","author":"Williamson","year":"2021","journal-title":"Eur J Pediatr"},{"issue":"2","key":"joi230065r7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MOP.0000000000000999","article-title":"Genetic testing for unexplained perinatal disorders.","volume":"33","author":"Hays","year":"2021","journal-title":"Curr Opin Pediatr"},{"issue":"12","key":"joi230065r8","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2017.3438","article-title":"Use of exome sequencing for infants in intensive care units.","volume":"171","author":"Meng","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"2","key":"joi230065r9","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2252","article-title":"Newborn sequencing in genomic medicine and public health.","volume":"139","author":"Berg","year":"2017","journal-title":"Pediatrics"},{"issue":"12","key":"joi230065r10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/ejhg.2014.289","article-title":"Whole-genome sequencing in newborn screening","volume":"23","author":"Howard","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"joi230065r11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/gtmb.2021.0246","article-title":"Whole genome screening for sick newborns.","volume":"25","author":"Terry","year":"2021","journal-title":"Genet Test Mol Biomarkers"},{"issue":"1","key":"joi230065r12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijns8010022","article-title":"Ethical considerations for equitable access to genomic sequencing for critically ill neonates in the United States.","volume":"8","author":"Fishler","year":"2022","journal-title":"Int J Neonatal Screen"},{"key":"joi230065r13","article-title":"Targeted next generation sequencing for newborn screening of Menkes disease.","volume":"24","author":"Parad","year":"2020","journal-title":"Mol Genet Metab Rep"},{"issue":"5","key":"joi230065r14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jmedgenet-2015-103263","article-title":"Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis.","volume":"53","author":"Trump","year":"2016","journal-title":"J Med Genet"},{"key":"joi230065r15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40246-015-0055-x","article-title":"Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.","volume":"9","author":"Lim","year":"2015","journal-title":"Hum Genomics"},{"issue":"1","key":"joi230065r16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s13023-021-02116-5","article-title":"NeoSeq: a new method of genomic sequencing for newborn screening.","volume":"16","author":"Wang","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"joi230065r17","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.796","article-title":"Targeted gene panel sequencing for the rapid diagnosis of acutely ill infants.","volume":"7","author":"Brunelli","year":"2019","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"joi230065r18","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.5906","article-title":"Novel variant findings and challenges associated with the clinical integration of genomic testing.","volume":"175","author":"Maron","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"8","key":"joi230065r19","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","article-title":"ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing.","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"issue":"1","key":"joi230065r20","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1038\/s41467-022-31446-6","article-title":"An automated 13.5?hour system for scalable diagnosis and acute management guidance for genetic diseases.","volume":"13","author":"Owen","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"joi230065r21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"joi230065r22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","article-title":"Technical standards for the interpretation and reporting of constitutional copy-number variants.","volume":"22","author":"Riggs","year":"2020","journal-title":"Genet Med"},{"issue":"3","key":"joi230065r24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/oxfordjournals.aje.a117428","article-title":"Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard.","volume":"141","author":"Joseph","year":"1995","journal-title":"Am J Epidemiol"},{"issue":"4","key":"joi230065r25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/0272989X9601600412","article-title":"Inferences for likelihood ratios in the absence of a \u201cgold standard\u201d.","volume":"16","author":"Joseph","year":"1996","journal-title":"Med Decis Making"},{"issue":"3","key":"joi230065r28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/(ISSN)1096-8628","article-title":"Kabuki make-up (Niikawa-Kuroki) syndrome.","volume":"31","author":"Niikawa","year":"1988","journal-title":"Am J Med Genet"},{"issue":"2","key":"joi230065r29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/(ISSN)1096-8628","article-title":"Growth, behavior, and clinical findings in 27 patients with Kabuki (Niikawa-Kuroki) syndrome.","volume":"127A","author":"White","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"6","key":"joi230065r30","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ajhg.2016.03.024","article-title":"Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing exploratory research consortium.","volume":"98","author":"Amendola","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"5","key":"joi230065r31","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ajhg.2020.09.011","article-title":"Variant classification concordance using the ACMG-AMP variant interpretation guidelines across nine genomic implementation research studies.","volume":"107","author":"Amendola","year":"2020","journal-title":"Am J Hum Genet"},{"key":"joi230065r23","unstructured":"Athena Diagnostics. Newborn DX: advanced sequencing evaluation. Accessed June 24, 2023.? https:\/\/www.athenadiagnostics.com\/newborndx"},{"key":"joi230065r26","unstructured":"Centers for Disease Control and Prevention. National Vital Statistics System: birth data. Accessed June 24, 2023.? https:\/\/www.cdc.gov\/nchs\/nvss\/births.htm"},{"key":"joi230065r27","unstructured":"Centers for Disease Control and Prevention. Assisted reproductive technology success rates. Accessed June 24, 2023. https:\/\/www.cdc.gov\/art\/artdata\/index.html"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2807081\/jama_maron_2023_oi_230065_1688654427.09424.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T11:01:10Z","timestamp":1689073270000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2807081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,7,11]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.9350","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,11]]}}}